Literature DB >> 34354274

COVID vaccine boosters: the most important questions.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  Immunology; SARS-CoV-2; Vaccines

Year:  2021        PMID： 34354274     DOI： 10.1038/d41586-021-02158-6

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.

Authors:  Madhumita Shrotri; Annalan M D Navaratnam; Vincent Nguyen; Thomas Byrne; Cyril Geismar; Ellen Fragaszy; Sarah Beale; Wing Lam Erica Fong; Parth Patel; Jana Kovar; Andrew C Hayward; Robert W Aldridge
Journal:  Lancet       Date:  2021-07-17       Impact factor: 79.321
  1 in total
  37 in total

Review 1.  An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations.

Authors:  Bulent Kantarcioglu; Omer Iqbal; Joseph Lewis; Charles A Carter; Meharvan Singh; Fabio Lievano; Mark Ligocki; Walter Jeske; Cafer Adiguzel; Grigoris T Gerotziafas; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

2.  Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models.

Authors:  Sita Awasthi; James J Knox; Angela Desmond; Mohamad-Gabriel Alameh; Brian T Gaudette; John M Lubinski; Alexis Naughton; Lauren M Hook; Kevin P Egan; Ying K Tam; Norbert Pardi; David Allman; Eline T Luning Prak; Michael P Cancro; Drew Weissman; Gary H Cohen; Harvey M Friedman
Journal:  J Clin Invest       Date:  2021-12-01       Impact factor: 14.808

3.  Durability analysis of the highly effective BNT162b2 vaccine against COVID-19.

Authors:  Arjun Puranik; Patrick J Lenehan; John C O'Horo; Colin Pawlowski; Michiel J M Niesen; Abinash Virk; Melanie D Swift; Walter Kremers; A J Venkatakrishnan; Joel E Gordon; Holly L Geyer; Leigh Lewis Speicher; Venky Soundararajan; Andrew D Badley
Journal:  PNAS Nexus       Date:  2022-06-08

Review 4.  Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries.

Authors:  Fabrizio Bert; Giacomo Scaioli; Lorenzo Vola; Davide Accortanzo; Giuseppina Lo Moro; Roberta Siliquini
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

Review 5.  Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron.

Authors:  Jerard Seghatchian; Paulo Pereira; Francesco Lanza
Journal:  Transfus Apher Sci       Date:  2022-07-03       Impact factor: 2.596

Review 6.  Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines.

Authors:  Mohammad Reza Sepand; Banafsheh Bigdelou; Jim Q Ho; Mohammad Sharaf; Alexis J Lannigan; Ian M Sullivan; Alecsander P da Silva; Leland O Barrett; Scott McGoldrick; Yuvraj Lnu; Shannon E Lynch; Jared M Boisclair; Dakarai D Barnard-Pratt; Steven Zanganeh
Journal:  Antibodies (Basel)       Date:  2022-05-12

7.  Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].

Authors:  Xuan Ying Poh; I Russel Lee; Clarissa Lim; Jefanie Teo; Suma Rao; Po Ying Chia; Sean W X Ong; Tau Hong Lee; Ray J H Lin; Lisa F P Ng; Ee Chee Ren; Raymond T P Lin; Lin-Fa Wang; Laurent Renia; David Chien Lye; Barnaby E Young
Journal:  Trials       Date:  2022-06-16       Impact factor: 2.728

8.  SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Authors:  Tara M Narowski; Kristin Raphel; Lily E Adams; Jenny Huang; Nadja A Vielot; Ramesh Jadi; Aravinda M de Silva; Ralph S Baric; John E Lafleur; Lakshmanane Premkumar
Journal:  Cell Rep       Date:  2022-01-20       Impact factor: 9.995

9.  Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study.

Authors:  Tesfaye Yadete; Kavita Batra; Dale M Netski; Sabrina Antonio; Michael J Patros; Johan C Bester
Journal:  Vaccines (Basel)       Date:  2021-12-02

10.  Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland.

Authors:  Mateusz Babicki; Agnieszka Mastalerz-Migas
Journal:  Vaccines (Basel)       Date:  2022-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.